SKN (ASX) Ann: new issue

Originally posted by Immetoday: ↑

If you had an understanding of the company and their history then you would have known about this maxy....clearly shows it’s just another reactive jab by you clutching at straws to try and find a negative.

This has been expected for a long time............this is a rather big deal and should result in new income streams for us in future, possibly worldwide income streams.

For holders who are interested - we have just purchased the intellectual property (IP) for the active ingredient that was tested and proven to kill the covid surrogate (sole right to it and ability to license out and collect royalties)......note that it doesn’t just kill covid surrogate, basically kills 99.99% of germs like any other high grade product. (Feel free to argue this maxy but it’s been lab proven)

Look at it this way as an example of another company who owns the rights to a similar product (tested to do same)....HCT buys pathoway from the company holding IP for it....there was/is an agreement to then onsell it to us. There are other companies across the world who also buy and use pathoway as an additive for their products (it was the original plan for our product before the SE formula was tested). We basically have a product that does the same thing as pathoway and will be able to sell and collect royalties for use. (Here’s where maxi will have a go, yep there was a binding agreement for us to buy pathoway from HCT.....we don’t need this anymore as we have developed an ingredient that does the same thing.....which we can make money from by selling as a competitor to pathoway. This may cost us to get out of the agreement but I’d say we can negotiate pur way out of it , even if we can’t it will cost us $600k max.....but I’d rather have our own ingredient that we can onsell moving forward than be locked into supplying a product with someone elses product for ever more. The $600k will be made back by the sales our our IP protected product to other suppliers in the near term)

Maxy.......before you start yelling and screaming answer these five questions and save yourself looking stupid.....

Does HCT buy pathoway from another party to add to their product as the active ingredient? (Answer - yes)
Is the active ingredient in the HCT product what kills the nasties (answer -yes)
Does the company that supplies pathoway sell it worldwide as an active ingredient in sanitisers (answer - yes)
Does the supplier of pathoway own the IP for it and as such is the only company able to supply it (answer - yes)
Do we have a lab tested product that we own the IP for that is a direct competitor to pathoway (answer - yes)

Dont get confused by my comparison with HCT above.....they don’t own the rights to the active product that kills covid, they buy that.
SKN does own an active product that kills covid.

Expand

Good post and I take your point.

What looks sus is the low price and form of payment. If it is indeed such a big deal, why did it not command a higher price? Especially in the current environment any reasonable person would think that the IP would be worth a lot more. Wouldn't other companies be willing to pay a lot more for the IP?

Even if it is a related party transaction I would have thought it would have a higher price. Directors of any company, not just SKN, don't give away assets out of the goodness of their hearts and in fact in most cases they extract as much as they can.

Maybe there is other consideration besides the 250k shares? If so, why not disclose it to the market.

No.	Vol.	Price($)
1	1000000	0.4¢

No.

Vol.

Price($)

1000000

0.4¢

Price($)	Vol.	No.
0.5¢	468369	2

Price($)

Vol.

No.

0.5¢

468369

No.	Vol.	Price($)
1	1000000	0.004
8	6150582	0.003
4	2335000	0.002
9	6802098	0.001
0	0	0.000

No.

Vol.

Price($)

1000000

0.004

6150582

0.003

2335000

0.002

6802098

0.001

0.000

Price($)	Vol.	No.
0.005	468369	2
0.006	802110	3
0.007	1462270	3
0.009	30000	1
0.015	475977	1

Price($)

Vol.

No.

0.005

468369

0.006

802110

0.007

1462270

0.009

30000

0.015

475977

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $2.357M

Open	High	Low	Value	Volume
0.4¢	0.4¢	0.4¢	$4.497K	1.124M

Ann: new issue, page-47

Finding financial stability when inflation's out of control

Bitcoin: Current State of Play & Where to Next | Swyftx

Cokal plans to kick off unexpected underground mine in Indonesia

Sarytogan promises good returns on Kazakhstan project, but the market is uncertain

Emerald & Azure score Digger & Dealer awards

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: new issue, page-47

Top Stories

Finding financial stability when inflation's out of control

Bitcoin: Current State of Play & Where to Next | Swyftx

Cokal plans to kick off unexpected underground mine in Indonesia

Sarytogan promises good returns on Kazakhstan project, but the market is uncertain

Emerald & Azure score Digger & Dealer awards

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News